Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC0499 Ag-5473
Novel potent FKBP12 ligand
More description
DCC0498 Ag2034
Inhibitor of the glycinamide ribonucleotide formyltransferase (GARFT)
More description
DCC0497 Ag1529
Novel capsaicinoid-based soft drug, attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability
More description
DCC0496 Ag1433
Potent inhibitor of tyrosine kinases; Direct and selective inhibitor of photosynthetic PEP carboxylase; Inhibitor of PDGFR-β, Flk-1, and angiogenesis
More description
DCC0494 Ag-012986
pan-Cyclin dependent kinase (CDK) inhibitor
More description
DCC0493 Aftobetin
Probe used for Early detection of Alzheimer's disease
More description
DCC0492 Afn941
Staurosporine analog, acting as a Jak3-specific inhibitor
More description
DCC0491 Aflatoxin B2
Natural Potent Hepatocarcinogen
More description
DCC0490 Aflatoxin B1
Quantity (mg or Unit) Unit Price ($/mg or $/Unit) Final Price 100 $36.45 Total: $3,645.00 50 $42.12 Total: $2,106.00 25 $49.41 Total: $1,235.25 10 $58.32 Total: $583.20 5 $68.85 Total: $344.25
More description
DCC0489 Af-399/42018025
Novel CC chemokine receptor 4 (CCR4) antagonist
More description
DCC0488 af-353 Hydrochloride
Potent antagonist of P2X3 and P2X2/3
More description
DCC0487 Af3442
Novel inhibitor of human microsomal prostaglandin E synthase-1 (mPGES-1)
More description
DCC0486 Aerobactin
Bacterial iron chelating agent as a siderophore and an Escherichia coli metabolite
More description
DCC0485 aeg3482 Sodium Salt
Novel inhibitor of Jun kinase activity and cell death through induced expression of heat shock protein 70
More description
DCC0484 Adx68693
Novel inhibitor of hFSHR (104 nM) and hLHR (314 nM), showing no activity with hTSHR at 30 μM
More description
DCC0483 Adx68692
Novel Nonsteroidal Negative Allosteric Modulator of Follicle-Stimulating Hormone Receptor (FSHR)
More description
DCC0482 Adx61623
Novel Nonsteroidal Negative Allosteric Modulator of Follicle-Stimulating Hormone Receptor (FSHR)
More description
DCC0481 Adtl-ei1712
The first selective dual-target inhibitor of ERK1 and ERK5
More description
DCC0480 Adt-061
Novel PDE10 inhibitor, reducing oncogenic β-catenin, suppressing TCF/LEF transcription
More description
DCC0479 Ads-j1
Inhibitor of semen-derived amyloid fibril formation, blocking fibril-mediated enhancement of HIV-1 infection
More description
DCC0478 Ads-103317
Novel Inhibitor of EGF-EGFR Interactions
More description
DCC0477 Adrenaline Sulfate
Nonselective agonist of all adrenergic receptors, including the major subtypes alpha1, alpha2, ß1, ß2, and ß3
More description
DCC0476 Adr-925
Active iron-chelating metabolite of dexrazoxane
More description
DCC0475 Adp-hpd
Poly(ADP-Ribose) Glycohydrolase (PARG) inhibitor
More description
DCC0474 Adp-2341
Novel soluble analog of FiVe1
More description
DCC0473 Adjuvant Nada
Novel antibiotic adjuvant, exhibiting as high as 4096-fold potentiation of multiple classes of antibiotics toward critical Gram-negative superbugs
More description
DCC0472 Adjuvant
Novel antibiotic adjuvant, exhibiting as high as 4096-fold potentiation of multiple classes of antibiotics toward critical Gram-negative superbugs
More description
DCC0471 Ad-isec
Novel Potent Mutant p53 Rescuing Agent
More description
DCC0470 Adinazolam Mesylate
Antidepressant and anxiolytic agent, binding to peripheral-type benzodiazepine receptors that interact allosterically with GABA receptors as an agonist to produce inhibitory effects
More description
DCC0469 Aderbasib
Novel sheddase inhibitor, inhibiting the ADAM (A Disintegrin And Metalloprotease) family of multifunctional membrane-bound proteins with potential antineoplastic activity
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X